INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "ENGINEERED IMINE REDUCTASES AND METHODS OF USE THEREOF"

GENEVA, Jan. 6 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/035174) for "ENGINEERED IMINE REDUCTASES AND METHODS OF USE THEREOF" on Jun 25, 2025. With publication no. WO/2026/006398, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JUDD, Ted, Charles (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), ORTIZ, Adrian (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), VERNON, Robert, McCoy (c/o Amg...